Patent · US Expired

Anxiety method

US6150365A · kind A · utility

9Cited by
6References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 6, 2000
Grant dateNov 21, 2000
Priority date
Expiry dateJun 6, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

6-Hydroxy-8-[4-[4-(2-pyrimidinyl)-piperazinyl]-butyl]-8-azaspiro[4.5]-7,9-d ione and its pharmaceutically acceptable salts and hydrates are useful in the alleviation of anxiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.